October 2015 Newsletter

October 8, 2015:

Charges of Pharmaceutical Price Gouging Besiege Valeant

The fast-growing firm saw its stock price drop 35 percent after intense scrutiny of rising drug costs.

October 8, 2015:

Steady Rise in Global Ophthalmic Surgery Fuels Single-Use Device Market

The market is expected to generate $2.8 billion in sales in 2015, growing to $3.4 billion by 2020.

October 8, 2015:

MIGS Devices Spur Cataract Surgeons to Treat Glaucoma

Glaucoma surgeries are expected to rise to nearly 1.4 million by 2020.

October 8, 2015:

Millennial Eye Live Meeting Looks at New Technology from Perspective of Practice

Doctors openly shared surgical experiences and the best choices for a successful outcome.

October 8, 2015:

Percentage of Surgeons Offering FLCS Hits All-Time High; Procedure Volume Lags

39 percent of US cataract surgeons now have access to femtosecond technology, according to Market Scope’s Q2-2015 survey.

October 8, 2015:

MacuLogix Raises $5 Million to Expand Sales of AdaptDx

The funding will also help launch the product in Europe in 2016.

October 8, 2015:

Ophthalmologist, Inventor Jan Worst Dies at 87

The creator of the “iris claw” lens (now known as the Artisan) also founded Ophtec with his wife.

October 8, 2015:

Moorfields Performs First Stem Cell Procedure for Wet AMD

The operation was part of an ongoing clinical trial assessing the use of cultured retinal pigment epithelial cells derived from human embryonic stem cells.

October 8, 2015:

Is the UK’s National Health Service Facing Collapse?

The publicly funded health care system is a frequent political football, but concerns over its future appear to be taking on new urgency.

October 8, 2015:

October 2015 News Briefs

Social media